Literature DB >> 16276409

All neuropathies great and small.

Ellen B Penny1, Brian D McCabe.   

Abstract

Autosomal-dominant pure hereditary spastic paraplegia (AD-HSP) is characterized by the degeneration of long axons in corticospinal tracts and dorsal columns, resulting in spasticity and difficulty walking. Mutations in the SPG4 gene product spastin are the predominant genetic lesions associated with this inherited disease. In this issue, Orso et al. examine and reconcile existing Drosophila mutants of spastin and generate a new model for HSP by overexpression of a fly spastin transgene that carries a mutation prevalent in human AD-HSP (see the related article beginning on page 3026). Expression of this mutant spastin protein produces pathology in flies reminiscent of the human disease, including adult locomotion defects, in addition to causing aberrant synaptic morphology and altered microtubule stability. Both movement and synaptic defects in fly mutants were ameliorated by treatment with the microtubule-modifying agent vinblastine. The results are consistent with disease-causing mutations in human spastin producing dominant-negative proteins and confirm the usefulness of Drosophila genetic techniques to understand HSP and other neurodegenerative diseases.

Entities:  

Mesh:

Year:  2005        PMID: 16276409      PMCID: PMC1265885          DOI: 10.1172/JCI27003

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Human neurodegenerative disease modeling using Drosophila.

Authors:  Nancy M Bonini; Mark E Fortini
Journal:  Annu Rev Neurosci       Date:  2003-04-10       Impact factor: 12.449

Review 2.  Hereditary spastic paraplegia: spastin phenotype and function.

Authors:  John K Fink; Shirley Rainier
Journal:  Arch Neurol       Date:  2004-06

3.  The genetics of Drosophila transgenics.

Authors:  Gregg Roman
Journal:  Bioessays       Date:  2004-11       Impact factor: 4.345

Review 4.  Neurological complications of antineoplastic therapy.

Authors:  W R Shapiro; D F Young
Journal:  Acta Neurol Scand Suppl       Date:  1984

Review 5.  Can flies help humans treat neurodegenerative diseases?

Authors:  J Lawrence Marsh; Leslie Michels Thompson
Journal:  Bioessays       Date:  2004-05       Impact factor: 4.345

6.  Neuromuscular defects in a Drosophila survival motor neuron gene mutant.

Authors:  Yick Bun Chan; Irene Miguel-Aliaga; Chris Franks; Natasha Thomas; Barbara Trülzsch; David B Sattelle; Kay E Davies; Marcel van den Heuvel
Journal:  Hum Mol Genet       Date:  2003-06-15       Impact factor: 6.150

7.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

8.  Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

Authors:  J M Warrick; H L Paulson; G L Gray-Board; Q T Bui; K H Fischbeck; R N Pittman; N M Bonini
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

9.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

10.  The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function.

Authors:  Nick Trotta; Genny Orso; Maria Giovanna Rossetto; Andrea Daga; Kendal Broadie
Journal:  Curr Biol       Date:  2004-07-13       Impact factor: 10.834

View more
  1 in total

1.  An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion.

Authors:  Christian Beetz; Anders O H Nygren; Thomas Deufel; Evan Reid
Journal:  Neurogenetics       Date:  2007-07-27       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.